Latest News
Seroba Kernel to Sponsor Major European Medtech Conference.
Seroba Kernel is delighted to announce that it is sponsoring the upcoming IN3 European Medtech Conference. It will be held in Dublin this coming April 16th-18th 2013. As Ireland is home to one of the largest medical device clusters in Europe, we think Dublin is a great location in w
Veryan Receives CE Mark Approval for BioMimics 3D™ Stent
16 November 2012 – Seroba Kernel investee company, Veryan Medical, the vascular disease specialist, has received CE Mark approval for the BioMimics 3D™ stent, its novel platform technology designed for treatment of the superficial femoral and proximal popliteal (femoropopliteal) arteries
Biosensia appoints James D. Merselis as Non-Executive Director.
Dublin, 23 October 2012 … Biosensia ltd., a Seroba Kernel backed point of care diagnostics Company, today announces the appointment of James D. Merselis as Non-Executive Director. Jim is currently a non-executive director at Trinity Biotech (NASDAQ: TRIB) and a consultant to healthcare diag
Previous123456789101112Next